Study Reveals High Sickle Cell Disease Burden on Long Island, Highlighting Healthcare Challenges
A recent study conducted by researchers at NYU School of Global Public Health has identified Long Island as having a significant burden of sickle cell disease (SCD), a common inherited blood disorder affecting approximately 100,000 Americans. The study analyzed data from 42,200 SCD hospitalizations in New York State between 2009 and 2022, focusing on hospital stay lengths, total charges, illness severity, and mortality risk. Findings indicate that Long Island had the highest percentage of hospitalizations with a major risk of death, suggesting a high burden of SCD in the region. The study also noted that most SCD patients in New York are of African descent, with young adults aged 18 to 29 accounting for the largest share of hospitalizations. The research highlights the need for improved care transition from pediatric to adult services and suggests that regional differences in SCD management could be addressed to enhance patient outcomes. 
